Revvity Inc.
USUSDRevvity Inc. (LSE:0KHE) — Biotechnology: Laboratory Analytical Instruments. Aantal beurzen waarop de aandelen van het bedrijf worden verhandeld: 3. Op deze pagina — koers en grafiek, dividenden, grootste aandeelhouders en historiek van het aantal aandelen.
Over het Bedrijf
- Website
- revvity.com
- Sector
- Industrials · Biotechnology: Laboratory Analytical Instruments
- Hoofdkantoor
- Waltham, United States
- CEO
- Prahlad R. Singh
- Werknemers
- 11 000
- Uitstaande Aandelen
- 111.59 mln. per 2026-08-06
- Free Float
- 102.49 mln.
- Marktkapitalisatie
- 16.63 mld. USD
- Insiders
- 0.26%
- Institutionele Beleggers
- 96.55%
- Branche (SIC)
- Laboratory Analytical Instruments
- Rechtsvorm
- ZJTK
- LEI
- 549300IKL1SDPFI7N655
- Uitkeringsratio
- 13.4%
- FCF
- 558 mln. USD6%
- Schuld
- 3.21 mld. USD3.9 jr FCF
- Dividendreeks
- 43 jr
- Winst, FCF en uitbetaalde dividenden — voor de 12 maanden tot 05.07.2026 (het laatste rapport van het bedrijf).
Beschrijving
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Dividenden
Revvity Inc. (RVTY) betaalt elk kwartaal dividend uit. Per jaar (12 maanden tot en met de laatst aangekondigde betaling): 0.28 USD per aandeel (betalingen: 4). Dat is ongeveer 0.18% van de huidige aandelenkoers. De volgende ex-dividenddatum is 23.10.2026: 0.07 USD per aandeel, betaald op 13.11.2026. Ononderbroken dividendgeschiedenis: 43 jaar.
| Ex-Datum | Uitbetaling | Bedrag | % | Type | Ticker |
|---|---|---|---|---|---|
| 2026-10-23 aangekondigd | 2026-11-13 | 0.0700 USD | 0.0/0.2 % | per kwartaal | US:RVTY |
| 2026-07-17 | 2026-08-07 | 0.0700 USD | 0.0/0.2 % | per kwartaal | US:RVTY |
| 2026-04-17 | 2026-05-08 | 0.0700 USD | 0.0/0.2 % | per kwartaal | US:RVTY |
| 2026-01-16 | 2026-02-06 | 0.0700 USD | 0.0/0.2 % | per kwartaal | US:RVTY |
| 2025-10-17 | 2025-11-07 | 0.0700 USD | 0.0/0.2 % | per kwartaal | US:RVTY |
| 2025-07-18 | 2025-08-08 | 0.0700 USD | 0.0/0.2 % | per kwartaal | US:RVTY |
| 2025-04-17 | 2025-05-09 | 0.0700 USD | 0.0/0.2 % | per kwartaal | US:RVTY |
| 2025-01-17 | 2025-02-07 | 0.0700 USD | 0.0/0.2 % | per kwartaal | US:RVTY |
| 2024-10-18 | 2024-11-08 | 0.0700 USD | 0.0/≈0.2 % | per kwartaal | US:RVTY |
| 2024-07-19 | 2024-08-09 | 0.0700 USD | 0.0/≈0.2 % | per kwartaal | US:RVTY |
| 2024-04-18 | 2024-05-10 | 0.0700 USD | 0.0/≈0.2 % | per kwartaal | US:RVTY |
Nieuws Deze Week
Persberichten van de investeerderswebsite van het bedrijf, dagelijks bijgewerkt. Links leiden naar de website van het bedrijf. De koppen zijn in de oorspronkelijke taal, zoals op de bedrijfswebsite.
| 06.10.2026 | Revvity to Host Investor Day |
Grootste Aandeelhouders
| Houder | Belang | Aandelen | Rapportdatum |
|---|---|---|---|
| T. Rowe Price Investment… | 16.37% | 18.26 mln. | 2026-06-30 |
| T. ROWE PRICE CAPITAL AP… | 10.2% | 11.38 mln. | 2026-06-30 |
| Jupiter Topco LLC | 7.74% | 8.64 mln. | 2026-06-30 |
| Edgepoint Investment Gro… | 7.66% | 8.54 mln. | 2026-06-30 |
| Blackrock Inc. | 6.86% | 7.66 mln. | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 7.3 mln. | 2026-06-30 |
| JANUS INVESTMENT FUND-Ja… | 5.15% | 5.75 mln. | 2026-06-30 |
| Price (T.Rowe) Associate… | 4.96% | 5.53 mln. | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.28% | 4.77 mln. | 2026-06-30 |
| State Street Corporation | 3.89% | 4.34 mln. | 2026-06-30 |
| Victory Capital Manageme… | 3.27% | 3.65 mln. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 3.55 mln. | 2026-06-30 |
| Dimensional Fund Advisor… | 3.07% | 3.43 mln. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 2.89 mln. | 2026-06-30 |
| -Price (T.Rowe) U.S. Val… | 2.41% | 2.69 mln. | 2026-06-30 |
| TR PRICE-Price (T.Rowe)… | 2.41% | 2.69 mln. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.29% | 2.56 mln. | 2026-06-30 |
| JNL Series Trust-JNL/T.… | 2.27% | 2.53 mln. | 2026-06-30 |
| Victory Portfolios-Victo… | 2.12% | 2.37 mln. | 2026-06-30 |
| T. Rowe Price Value Fund… | 1.93% | 2.16 mln. | 2026-06-30 |
| Invesco Exchange-Traded… | 1.67% | 1.87 mln. | 2026-08-31 |
| SINGH PRAHLAD R (Chief E… | ≈0.09% | 105 676 | 2026-08-13 |
| GOLDBERG JOEL S (General… | ≈0.09% | 105 223 | 2026-08-14 |
| BARRETT PETER (Director) | ≈0.03% | 28 293 | 2026-05-07 |
| WITNEY FRANKLIN R. PH.D.… | ≈0.02% | 23 354 | 2026-05-07 |
| CHAPIN SAMUEL R. (Direct… | ≈0.02% | 22 676 | 2026-05-07 |
| VICTOR MIRIAME (Officer) | ≈0.02% | 18 122 | 2026-02-24 |
| WITZ PASCALE (Director) | ≈0.01% | 15 985 | 2026-05-07 |
| KRAKOWIAK MAXWELL (Chief… | ≈0.01% | 14 781 | 2026-09-21 |
| MICHAS ALEXANDROS P (Dir… | — | — | 2026-08-25 |
| MICHAS ALEXIS P (Directo… | — | — | 2025-08-27 |
